248

Now a warning about the drug RISPERDAL or risperidone, manufactured by Janssen Pharmaceutica and used to treat schizophrenia. The WARNINGS section of the label for this drug now describes cerebrovascular adverse events in elderly patients being treated for dementia-related psychosis in clinical trials. These events, some of them fatal, included stroke and TIA. The warning goes on to say that RISPERDAL has not been approved for the treatment of patients with dementia-related psychosis. In a recent letter to practitioners, Janssen Pharmaceutica is offering additional information on these and other clinical trials conducted in elderly patients. Call the company at 1-800-JANSSEN. Additional Information: FDA MedWatch Safety Alert: RISPERDAL (risperidone). http://www.fda.gov/medwatch/SAFETY/2003/safety03.htm#risper

risperdal, warning, fda, risperidone, schizophrenia, stroke, tia, patient, safety, drug, reaction,